XDive® – The World’s First 5-Minute Real-Time PCR Instrument
OnsiteGene, a proud member of the NIH RADx initiative, is transforming molecular diagnostics with XDive®, the world’s first real-time PCR system that completes 40 thermal cycles and real-time fluorescent imaging in just 5 minutes (20uL reaction volume) — without compromising accuracy or sensitivity.
XDive integrates high-speed thermal cycling, advanced fluorescence optics (4–6 channels), and dried ultra-fast reagents into a compact, benchtop platform that delivers results faster than any system on the market. Each run processes up to 16 samples with 64-plex detection capability, enabling high-efficiency syndromic panel testing, infectious disease screening, and emergency response diagnostics.
Key innovations include:
The XDive platform has received FDA Emergency Use Authorization for COVID-19 and Monkeypox testing and is actively expanding into syndromic testing applications. Its OEM-ready modular design makes it suitable for integration into third-party systems and flexible use in laboratory, clinical, or mobile settings.
Visit us at Booth #416 to experience how XDive is redefining the speed and simplicity of molecular diagnostics. Now seeking global distributors and assay development partners.
XDive integrates high-speed thermal cycling, advanced fluorescence optics (4–6 channels), and dried ultra-fast reagents into a compact, benchtop platform that delivers results faster than any system on the market. Each run processes up to 16 samples with 64-plex detection capability, enabling high-efficiency syndromic panel testing, infectious disease screening, and emergency response diagnostics.
Key innovations include:
- Proprietary thermal block and sensor technology enabling unmatched ramp rates and thermal precision
- Dried ultra-fast TaqMan® chemistry, eliminating cold-chain requirements (6-month room temperature shelf life)
- Intuitive software interface with streamlined workflow for plug-and-play usability
- Editable panel compatibility that accelerates assay development and regulatory submissions
The XDive platform has received FDA Emergency Use Authorization for COVID-19 and Monkeypox testing and is actively expanding into syndromic testing applications. Its OEM-ready modular design makes it suitable for integration into third-party systems and flexible use in laboratory, clinical, or mobile settings.
Visit us at Booth #416 to experience how XDive is redefining the speed and simplicity of molecular diagnostics. Now seeking global distributors and assay development partners.
Category Press Releases